Providing barrier-free, timely access to data on emergence and spread of
antimicrobial resistance (AMR) in humans and animals and healthcare-associated infections (HAI)
Antimicrobial resistance surveillance
Genetic capabilities of bacteria and indiscriminate use of antimicrobials have resulted in wide-spread development of resistance,
hindering effectiveness of antibiotic therapy. Infection control prevention and measures and prescribing of appropriate
and effective empiric antibiotic therapy in patients with infections rely on tracking and reporting of resistant bacteria
and their infections through surveillance.
View and compare latest European surveillance data
Established in 2015 under the COMBACTE-MAGNET consortium of the New Drugs for Bad Bugs (ND4BB) programme,
the epidemiology network (EPI-Net) is an unprecedented collaboration of epidemiology experts. Read more.
Need help with Epi-NET?
Learn more about how to use our website and find answers to your questions.
EPI-Net receives support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n°115737,
resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013)
and EFPIA companies’ in kind contribution.
The website works best with Mozilla Firefox and Google Chrome.
Read more on browser/device requirements.